Evidence Hub

Quercetin exerts bidirectional regulation effects on the efficacy of tamoxifen in estrogen receptor‐positive breast cancer therapy: An in vitro study

Zhi-Xiang Xu, Dimeng Zhao, Xianyao Zheng, Bin Huang, X. Xia, Xue-Jun Pan

Environmental Toxicology, 2020

33 citations

Abstract

Tamoxifen was widely applied in the therapy of estrogen receptor (ER)‐positive breast cancer. With the purpose of determining the potential impacts of quercetin on its effectiveness, MCF‐7 cells were selected as the in vitro model and several cellular biological behaviors (ie, cell proliferation, migration, invasion, cycle, apoptosis, and oxidative stress) were investigated. As results, quercetin showed contrasting dose‐response to cellular behaviors dependent on the ROS‐regulated p53 signaling pathways. In detail, quercetin promoted cell proliferation and inhibited cell apoptosis at low concentrations, whereas high‐concentration resulted in apoptosis induction. Moreover, quercetin at a low concentration significantly inhibited tamoxifen‐induced antiproliferation in MCF‐7 cells, whereas high concentrations enhanced cell apoptosis in a synergetic manner. The real‐time quantitative polymerase chain reaction analysis further implied that quercetin exerted its dual roles in tamoxifen‐induced antiproliferative effects by regulated the gene expression involved in cell metastasis, cycle, and apoptosis through the ER pathways. Our present study provides a considerable support to the combination of quercetin and tamoxifen on human ER‐positive breast carcinoma management.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free